Genes that cause rare hidden cancer revealed
Several genes that cause sarcoma have been identified in the first comprehensive genetic map of sarcomas. The research has wide...
Jan 27, 2023
Stopping a rare childhood cancer in its tracks
Scientists at Cold Spring Harbor Laboratory (CSHL) have discovered a new drug target for Ewing sarcoma, a rare kind of cancer usually...
Jan 26, 2023
Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed
Ongoing trials are showing that a cancer vaccine may be able to overcome some of the other issues that are present with immune-based...
Jan 25, 2023
New research identifies a potential treatment target for hepatoblastoma in children
In a novel study appearing in The American Journal of Pathology, investigators studying a mouse model of hepatoblastoma report that the ...
Jan 24, 2023
Loneliness May Lead to Chronic Conditions Emotional Distress in Young Adult Cancer Survivors
Young adult childhood cancer survivors may have an increased risk for loneliness, which may be linked to new-onset chronic conditions and...
Jan 23, 2023
Canadian Pediatric Cancer Consortium launches to advance research in paediatric cancer care
Cancer is the leading cause of death from disease in children and adolescents in Canada, with 1,500 children newly diagnosed each year....
Jan 20, 2023
Oncological emergencies: A must know condition for families with childhood cancer
Oncological emergencies are defined as any acute, morbid or life-threatening events among children suffering from cancer which are...
Jan 19, 2023
Colin Seaman is the boy with the Harry Potter cells
"While developing a treatment plan, Lee introduced the family to a revolutionary treatment option for some patients with leukemia....
Jan 18, 2023
New drug combination may effectively treat often fatal childhood brain tumor
Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...
Jan 17, 2023
New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment
Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...
Jan 12, 2023

